|
Senior Investigator, Lady Davis Institute at the Jewish General Hospital
Associate Professor, Departments of Oncology, Psychiatry and Psychology, McGill University
Dr. Rosberger was (until 2017) the Chief of the Psychology Department at the Jewish General Hospital, providing exemplary clinical care to patients and their families. He also spearheaded the development of the Louise Granofsky-Psychosocial Oncology Program at the Segal Cancer Centre of the Jewish General Hospital. He participated on numerous provincial and national committees advocating for improvement of the emotional care for cancer patients and their families. He participated in the development of the National Distress Screening Guidelines (Canadian Partnership Against Cancer-CPAC), which were subsequently endorsed by multiple agencies (e.g, WHO, UICC, etc.) and implemented internationally. From 2004-2006, he was President of the Canadian Association of Psychosocial Oncology. At the same time, he sat on the management committee of the Canadian Strategy for Cancer Control, a coalition of advocacy and professional groups who successfully lobbied the federal government to create CPAC. Dr. Rosberger is currently vice-president of HPV Global Action, an NGO which provides educational resources about sexual health and is developing partnerships and programs nationally and internationally (in sub-Saharan Africa) in the prevention of Human Papillomavirus-related cancers.
Major Research Activities
Over a number of decades, Dr. Rosberger has led research programs in multiple areas of psychosocial oncology. His current research focus is on the prevention of Human Papillomavirus (HPV), a sexually transmitted infection, and HPV- related diseases (e.g., cervical cancer, penile cancer, genital warts, oropharyngeal cancer). His studies examine psychosocial correlates and predictors of Pap screening, HPV testing, and uptake of the HPV vaccine in several populations. More specifically, he investigates HPV vaccine decision-making in young adults who are at high risk for infection, as well as parents of young boys and girls. His interests in this area relate to vaccine hesitancy and measurement tools to identify factors influencing hesitancy that would inform the development of effective interventions. More recently, he has been funded by CIHR to examine the knowledge, attitudes and beliefs of Canadian women to inform public policy as provinces move from primary Pap to primary HPV DNA testing over the next few years. Dr. Rosberger is also studying vaccine-related issues arising from the COVID-19 pandemic. He was recently funded by the McGill Interdisciplinary Initiative in Infection and Immunity (MI4) to develop and test a video intervention using altruistic motives to promote COVID-19 vaccine uptake in young adults.
He has additional collaborative, research interests that span the cancer trajectory from prevention to survivorship issues, including recurrence. Specific studies have included: infertility distress in young male cancer patients, melanoma prevention, and psychosocial and coping concerns in adolescents and young adults with cancer. He was a principle investigator and is currently a co-investigator on several on-going CIHR and FRSQ grants examining the integration of patient-reported outcomes and symptom management in cancer care.
Recent Publications
Rodin, D., Dare, A.
J., Booker, R., Booth, C., Bryant, H., Ginsburg, O., Giuliani, M.,
Gospodarowicz, M., Gupta, S., Hammad, N., Rosberger, Z., Sutcliffe, S.,
& Earle, C. C. (2021). Transforming Canada's role in global cancer
control. The Lancet Oncology, 22(9), 400–409. doi:
10.1016/S1470-2045(21)00374-0.
Steben, M., Norris, T., Rosberger,
Z., & HPV Global Action (2020). COVID-19 Won't Be the Last (Or Worst)
Pandemic: It's Time to Build Resilience Into Our Cervical Cancer Elimination
Goals. Journal of obstetrics and gynaecology Canada, 42(10),
1195–1196. doi: 10.1016/j.jogc.2020.08.006.
Tatar O., Wade K., McBride E., Thompson E., Head K.J, Perez S., Shapiro G.K., Waller J., Zimet G., Rosberger Z. (2019, in press). Are healthcare professionals prepared to implement HPV testing? A review of psychosocial determinants of HPV test acceptability in primary screening for cervical cancer. Journal of Women’s Health. doi: 10.1089/jwh.2019.7678.
Tatar O., Shapiro G.K., Perez S., Wade K., Rosberger Z. (2019). Using the Precaution Adoption Process Model to Clarify Human Papillomavirus Vaccine Hesitancy in Canadian Parents of Girls and Parents of Boys. Human Vaccines & Immunotherapeutics. doi: 10.1080/21645515.2019.1575711.
Aubin, S. Rosberger, Z., Hafez, N., Noory, M. R., Lehmann, S., Batist, G., Kavan, P. (2019) Cancer!? I don’t have time for that: Impact of a psychosocial intervention for young adults with cancer. Journal of Adolescent and Young Adult Oncology. DOI: 10.1089/jayao.2017.0101.
Shapiro, G.K., Tatar, O.,
Dube, E., Amsel, R., Knauper, B., Naz , A., Perez , S., Rosberger, Z.
(2018) The vaccine hesitancy scale: Psychometric properties and validation. Vaccine.
36(5):660-667. doi: 10.1016/j.vaccine.2017.12.043.
Shapiro, G.K., Tatar, O., Amsel, R., Prue, G., Zimet, G., Knauper, B., Rosberger, Z. (2018). Using an integrated conceptual framework to investigate parents’ HPV vaccine decision for their daughters and sons. Preventive Medicine, 116, 203-210. doi: 10.1016/j.ypmed.2018.09.017.
Perez, S., Zimet, GD., Tatar, O., Stupiansky, NW., Fisher, WA., Rosberger, Z. Human Papillomavirus Vaccines: Successes and Future Challenges. (2018) Drugs, 78(14), 1385-1396.doi: 10.1007/s40265-018-0975-6. |